View Agent
| Agent Info | |
| Agent: | temsirolimus |
| Synonyms: | Torisel, CCI-779 |
| Drug Status For Certain Diseases: | Renal cell carcinoma(approved) |
| Classification: | a selective inhibitor of the mammalian target of rapamycin |
| Target: | Serine/threonine-protein kinase mTOR |
| KEGG Pathway: | Type II diabetes mellitus mTOR signaling pathway Glioma Choline metabolism in cancer Prostate cancer Acute myeloid leukemia Pathways in cancer AMPK signaling pathway Central carbon metabolism in cancer Insulin signaling pathway Adipocytokine signaling pathway PI3K-Akt signaling pathway HIF-1 signaling pathway Thyroid hormone signaling pathway MicroRNAs in cancer |
| Wiki Pathway: | RANKL/RANK Signaling Pathway Insulin Signaling TOR Signaling Interferon type I signaling pathways Prostate Cancer FSH signaling pathway Leptin signaling pathway Type II diabetes mellitus AMPK Signaling Extracellular vesicle-mediated signaling in recipient cells MicroRNAs in cardiomyocyte hypertrophy Senescence and Autophagy in Cancer Wnt Signaling Pathway Netpath TSH signaling pathway Integrated Breast Cancer Pathway SREBP signalling Costimulation by the CD28 family PIP3 activates AKT signaling Oncostatin M Signaling Pathway ErbB Signaling Pathway Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) TSLP Signaling Pathway BDNF signaling pathway Polycystic Kidney Disease Pathway SREBF and miR33 in cholesterol and lipid homeostasis Alpha 6 Beta 4 signaling pathway Cardiac Hypertrophic Response EGF/EGFR Signaling Pathway Signaling by Insulin receptor |